Similar articles

• Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.

  Weinberg LE, Lurain JR, Singh DK, Schink JC. Weinberg LE, et al. Gynecol Oncol. 2011 May 1;121(2):285-9. doi: 10.1016/j.ygyno.2011.01.003. Epub 2011 Jan 21. Gynecol Oncol. 2011. PMID: 21256579
• [The modern management of malignant germ cell tumor of the ovary].

  Anteby SO, Samuelof A, Biran S. Anteby SO, et al. Harefuah. 1987 Feb 1;112(3):132-5. Harefuah. 1987. PMID: 3038713 Review. Hebrew. No abstract available.
• [Results of fertility preserving operations in malignant ovarian tumors].

  Kleine W. Kleine W. Zentralbl Gynakol. 1996;118(6):317-21. Zentralbl Gynakol. 1996. PMID: 8768006 Review. German.
• Malignant ovarian germ cell tumors: a single-institution experience.

  Cicin I, Eralp Y, Saip P, Ayan I, Kebudi R, Iyibozkurt C, Tuzlali S, Gorgun O, Topuz E. Cicin I, et al. Am J Clin Oncol. 2009 Apr;32(2):191-6. doi: 10.1097/COC.0b013e3181841f2e. Am J Clin Oncol. 2009. PMID: 19307952 Clinical Trial.
• Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).

  Vriesendorp R, Aalders JG, Sleijfer DT, Willemse PH, Bouma J, Mulder NH. Vriesendorp R, et al. Cancer Treat Rep. 1984 May;68(5):779-81. Cancer Treat Rep. 1984. PMID: 6202407